Combigene Financial Statements From 2010 to 2024
| COMBI Stock | SEK 2.60 0.06 2.26% |
Check Combigene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Combigene's main balance sheet or income statement drivers, such as , as well as many indicators such as . Combigene financial statements analysis is a perfect complement when working with Combigene Valuation or Volatility modules.
Combigene |
Combigene AB Company Operating Margin Analysis
Combigene's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Combigene Operating Margin | 0.42 % |
Most of Combigene's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Combigene AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Combigene AB has an Operating Margin of 0.4234%. This is 101.21% lower than that of the Healthcare sector and 100.38% lower than that of the Biotechnology industry. The operating margin for all Sweden stocks is 107.68% lower than that of the firm.
Combigene AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Combigene's current stock value. Our valuation model uses many indicators to compare Combigene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Combigene competition to find correlations between indicators driving Combigene's intrinsic value. More Info.Combigene AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.43 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Combigene AB is roughly 2.31 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Combigene's earnings, one of the primary drivers of an investment's value.About Combigene Financial Statements
Combigene shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Combigene investors may analyze each financial statement separately, they are all interrelated. The changes in Combigene's assets and liabilities, for example, are also reflected in the revenues and expenses on on Combigene's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
CombiGene AB engages in the development and commercialization of gene therapy for the treatment of neurological and psychiatric disorders. CombiGene AB was founded in 1999 and is headquartered in Lund, Sweden. Combigene operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 7 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Combigene Stock Analysis
When running Combigene's price analysis, check to measure Combigene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Combigene is operating at the current time. Most of Combigene's value examination focuses on studying past and present price action to predict the probability of Combigene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Combigene's price. Additionally, you may evaluate how the addition of Combigene to your portfolios can decrease your overall portfolio volatility.